PURPOSE: Antimicrobial prophylaxis (AMP) can reduce the risk of surgical site infection (SSI) in gastroenterological surgery; however, in Japan its use was not fully recognized before 2000. The first nationwide guideline was published in 2001, since when the use of AMP has improved gradually. We conducted this study to investigate the current implementation of AMP in colorectal surgery and adherence to recommended practices for preventing SSI in Japan. METHODS: A questionnaire survey was sent to hospitals accredited by the Japanese Society of Gastroenterological Surgery and the Japan Society for Surgical Infection (JSSI). The questionnaire focused on the AMP regimen used for colorectal surgery. RESULTS: Responses were received from 721 (58%) of the 1249 hospitals that were sent the survey. The initial AMP dose was administered within 1 h before incision at 94% of the responding institutions. AMP was discontinued within 24 h of surgery at only 10% of institutions. Second-generation cephalosporins were administered at 84% of the institutions. CONCLUSIONS: The appropriate use of AMP in colorectal surgery is incomplete in certified institutions in Japan. The fact that many institutions administer AMP for longer than recommended is a problem that needs to be addressed.
PURPOSE: Antimicrobial prophylaxis (AMP) can reduce the risk of surgical site infection (SSI) in gastroenterological surgery; however, in Japan its use was not fully recognized before 2000. The first nationwide guideline was published in 2001, since when the use of AMP has improved gradually. We conducted this study to investigate the current implementation of AMP in colorectal surgery and adherence to recommended practices for preventing SSI in Japan. METHODS: A questionnaire survey was sent to hospitals accredited by the Japanese Society of Gastroenterological Surgery and the Japan Society for Surgical Infection (JSSI). The questionnaire focused on the AMP regimen used for colorectal surgery. RESULTS: Responses were received from 721 (58%) of the 1249 hospitals that were sent the survey. The initial AMP dose was administered within 1 h before incision at 94% of the responding institutions. AMP was discontinued within 24 h of surgery at only 10% of institutions. Second-generation cephalosporins were administered at 84% of the institutions. CONCLUSIONS: The appropriate use of AMP in colorectal surgery is incomplete in certified institutions in Japan. The fact that many institutions administer AMP for longer than recommended is a problem that needs to be addressed.
Authors: Dale W Bratzler; Peter M Houck; Chesley Richards; Lynn Steele; E Patchen Dellinger; Donald E Fry; Claudia Wright; Allen Ma; Karina Carr; Lisa Red Journal: Arch Surg Date: 2005-02
Authors: Eloy Espin-Basany; Jose Luis Sanchez-Garcia; Manuel Lopez-Cano; Roberto Lozoya-Trujillo; Meritxell Medarde-Ferrer; Lluis Armadans-Gil; Laia Alemany-Vilches; Manuel Armengol-Carrasco Journal: Int J Colorectal Dis Date: 2005-04-21 Impact factor: 2.571
Authors: Oded Zmora; Steven D Wexner; Luay Hajjar; Taeseok Park; Jonathan E Efron; Juan J Nogueras; Eric G Weiss Journal: Am Surg Date: 2003-02 Impact factor: 0.688
Authors: Marcel Hochreiter; Maria Uhling; Leila Sisic; Thomas Bruckner; Alexandra Heininger; Andreas Hohn; Katja Ott; Thomas Schmidt; Marc Moritz Berger; Daniel Christoph Richter; Markus Büchler; Markus Alexander Weigand; Cornelius Johannes Busch Journal: Infection Date: 2018-06-05 Impact factor: 3.553